Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR3 | P49682 | 20/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5134978 | 0.90 | CXCR3 (0.36) | CXCR3 | |
| SCHEMBL5137622 | 0.89 | CXCR3 (0.44) | CXCR3 | |
| SCHEMBL5074803 | 0.89 | MEN1 (0.36) | CXCR3 | |
| SCHEMBL5135388 | 0.88 | CXCR3 (0.38) | CXCR3 | |
| SCHEMBL5136865 | 0.88 | TSHR (0.35) | CXCR3 | |
| SCHEMBL5136555 | 0.87 | CXCR3 (0.33) | CXCR3 | |
| SCHEMBL1912805 | 0.86 | PTGES (0.37) | CXCR3 | |
| SCHEMBL648843 | 0.86 | PTGES (0.37) | CXCR3 | |
| SCHEMBL648844 | 0.86 | PTGES (0.37) | CXCR3 | |
| SCHEMBL5137842 | 0.86 | MEN1 (0.40) | CXCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |